A semi-synthetic oligosaccharide conjugate vaccine candidate confers protection against Streptococcus pneumoniae serotype 3 infection

The identification of immunogenic glycotopes that render glycoconjugate vaccines protective is key to improving vaccine efficacy. Synthetic oligosaccharides are an attractive alternative to the heterogeneous preparations of purified polysaccharides that most marketed glycoconjugate vaccines are base...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cell Chem Biol
Main Authors: Parameswarappa, Sharavathi Guddehalli, Reppe, Katrin, Geissner, Andreas, Ménová, Petra, Govindan, Subramanian, Calow, Adam D. J., Wahlbrink, Annette, Weishaupt, Markus W., Monnanda, Bopanna Ponnappa, Bell, Roland Lawrence, Pirofski, Liise-anne, Suttorp, Norbert, Sander, Leif Erik, Witzenrath, Martin, Pereira, Claney Lebev, Anish, Chakkumkal, Seeberger, Peter H.
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5234679/
https://ncbi.nlm.nih.gov/pubmed/27818299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chembiol.2016.09.016
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares